Dr. Dennis Nemceff, MD

Dr. Nemceff practices at Pomerado Outpatient Surgical Center L P in Escondido, California.

Dr. Nemceff's NPI, 1427371228, was assigned on March 8, 2010. Dr. Nemceff graduated from Tartu State University - Institute of Medicine in 2002. Dr. Nemceff holds California license A123910.

Dr. Nemceff's primary practice is Pomerado Outpatient Surgical Center L P, at 2130 Citracado Pkwy, Escondido, CA 92029 in San Diego County. The practice phone is (858) 485-1111.

Dr. Nemceff's primary practice is Pomerado Outpatient Surgical Center L P in Escondido, California. Dr. Nemceff is also affiliated with Palomar Medical Center Downtown Escondido. The medical group on file is Palomar Health Medical Group. Dmand AI also links Dr. Nemceff to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nemceff practices, 5 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Nemceff's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Nemceff is board certified in vascular surgery by the American Board of Surgery. Dmand AI has Dr. Nemceff's licenses on file in 2 states: California and New York.

Dmand AI lists amputation, arterial blot clot /embolism, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery, leg revascularization and peripheral vascular disease among the conditions Dr. Nemceff treats.

CMS data shows 472 Medicare services from Dr. Nemceff across 11 procedure codes in 2024, for 110 Medicare patients. Medicare paid $54,198 for them.

CMS counts 110 Medicare patients who saw Dr. Nemceff in 2024. The largest group is 75 to 84, with 47 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nemceff's median patient age at 68, with 39% women.

In 2024, Dr. Nemceff wrote 226 Medicare Part D claims for 53 patients. 57% of them were for generic drugs. CMS names the drug for 128 of them, across 4 drugs with 11 or more claims each, at $84,455 in total drug cost. In 2023, CMS named 166 claims across 5 drugs.

Dr. Nemceff accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 76 procedures of removal of tissue by Dr. Nemceff, more than 83% of the clinicians it reports for that procedure.

Coronary artery bypass graft (CABG): 1 to 10 procedures (CMS shows small counts as a range)

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Nemceff. Dr. Nemceff's most frequent co-authors are Scott David Bricker, MD, Angela Lynn Neville, MD and David S. Plurad, MD.

CMS Open Payments shows 389 general payments to Dr. Nemceff from 61 drug and device companies from 2016 to 2025. Device or supply loans make up the largest share, 60% of the total. AngioDynamics, Inc. paid the most, $24,382.

Dr. Nemceff graduated from Tartu State University - Institute of Medicine in 2002.

Dr. Nemceff is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.